메뉴 건너뛰기




Volumn 70, Issue 13 PART 2, 2008, Pages 1092-1097

Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; GADOLINIUM; PLACEBO;

EID: 41549134730     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000285426.73143.f7     Document Type: Article
Times cited : (26)

References (17)
  • 2
    • 0035091667 scopus 로고    scopus 로고
    • European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis
    • and European/Canadian Glatiramer Acetate Study Group
    • Comi G, Filippi M, Wolinsky JS, and European/Canadian Glatiramer Acetate Study Group. European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis. Ann Neurol 2001;49:290-297.
    • (2001) Ann Neurol , vol.49 , pp. 290-297
    • Comi, G.1    Filippi, M.2    Wolinsky, J.S.3
  • 3
    • 0030773332 scopus 로고    scopus 로고
    • Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure
    • Stone LA, Frank JA, Albert PS, et al. Characterization of MRI response to treatment with interferon beta-1b: contrast-enhancing MRI lesion frequency as a primary outcome measure. Neurology 1997;49:862-869.
    • (1997) Neurology , vol.49 , pp. 862-869
    • Stone, L.A.1    Frank, J.A.2    Albert, P.S.3
  • 4
    • 0037069306 scopus 로고    scopus 로고
    • Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses
    • Rovaris M, Codella M, Moiola L, et al. Effect of glatiramer acetate on MS lesions enhancing at different gadolinium doses. Neurology 2002;59:1429-1432.
    • (2002) Neurology , vol.59 , pp. 1429-1432
    • Rovaris, M.1    Codella, M.2    Moiola, L.3
  • 5
    • 2442561768 scopus 로고    scopus 로고
    • Oral simvastatin treatment in relapsing-remitting multiple sclerosis
    • Vollmer T, Key L, Durkalski V, et al. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 2004;363:1607-1608.
    • (2004) Lancet , vol.363 , pp. 1607-1608
    • Vollmer, T.1    Key, L.2    Durkalski, V.3
  • 6
    • 84970857770 scopus 로고
    • Regression towards the mean
    • Bland JM, Altman DG. Regression towards the mean. BMJ 1994;308:1499.
    • (1994) BMJ , vol.308 , pp. 1499
    • Bland, J.M.1    Altman, D.G.2
  • 7
    • 84970851084 scopus 로고
    • Some examples of regression towards the mean
    • Bland JM, Altman DG. Some examples of regression towards the mean. BMJ 1994;309:780.
    • (1994) BMJ , vol.309 , pp. 780
    • Bland, J.M.1    Altman, D.G.2
  • 8
    • 6944249912 scopus 로고    scopus 로고
    • Biomarkers and surrogate outcomes in neurodegenerative disease: Lessons from multiple sclerosis
    • Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx 2004;1:284-294.
    • (2004) NeuroRx , vol.1 , pp. 284-294
    • Miller, D.H.1
  • 9
    • 5644300578 scopus 로고    scopus 로고
    • Disease-modifying therapy in MS: A critical review of the literature. Part I: analysis of clinical trial errors
    • Goodin DS. Disease-modifying therapy in MS: a critical review of the literature. Part I: analysis of clinical trial errors. J Neurol 2004;251(suppl 5):v3-v11.
    • (2004) J Neurol , vol.251 , Issue.SUPPL. 5
    • Goodin, D.S.1
  • 10
    • 0345601517 scopus 로고    scopus 로고
    • Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/ remitting multiple sclerosis
    • PRISMS Study Group
    • PRISMS Study Group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/ remitting multiple sclerosis. Lancet 1998;352:1498-1504.
    • (1998) Lancet , vol.352 , pp. 1498-1504
  • 11
    • 0032864616 scopus 로고    scopus 로고
    • Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon- β1a in relapsing-remitting multiple sclerosis
    • Li DK, Paty DW. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon- β1a in relapsing-remitting multiple sclerosis. Ann Neurol 1999;46:197-206.
    • (1999) Ann Neurol , vol.46 , pp. 197-206
    • Li, D.K.1    Paty, D.W.2
  • 12
    • 0040647877 scopus 로고
    • The multivariate Poisson-log normal distribution
    • Aitchison J, Ho CH. The multivariate Poisson-log normal distribution. Biometrika 1989;76:643-653.
    • (1989) Biometrika , vol.76 , pp. 643-653
    • Aitchison, J.1    Ho, C.H.2
  • 14
    • 0027418515 scopus 로고    scopus 로고
    • Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial
    • IFNB Multiple Sclerosis Study Group
    • IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1996;43:655-661.
    • (1996) Neurology , vol.43 , pp. 655-661
  • 15
    • 0029082566 scopus 로고
    • Copolymer 1 reduces relapse rate and improves disability in relapsing- remitting multiple sclerosis: Results of a phase III multicenter, double-blind placebo-controlled trial
    • Johnson KP, Brooks BR, Cohen JA, et al. Copolymer 1 reduces relapse rate and improves disability in relapsing- remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. Neurology 1995;45:1268-1276.
    • (1995) Neurology , vol.45 , pp. 1268-1276
    • Johnson, K.P.1    Brooks, B.R.2    Cohen, J.A.3
  • 16
    • 0008678962 scopus 로고    scopus 로고
    • Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis
    • Lawrence JD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294.
    • (1996) Ann Neurol , vol.39 , pp. 285-294
    • Lawrence, J.D.1    Cookfair, D.L.2    Rudick, R.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.